These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of i.v. enalaprilat in chronically treated hypertensive patients during cardiac surgery. Schuetz WH, Lindner KH, Georgieff M, Mueller S, Oertel F, Radermacher P, Gauss A. Acta Anaesthesiol Scand; 1998 Sep; 42(8):929-35. PubMed ID: 9773137 [Abstract] [Full Text] [Related]
23. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition. Verma SP, Silke B, Reynolds GW, Kelly JG, Richmond A, Taylor SH. J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019 [Abstract] [Full Text] [Related]
24. Enalaprilat decreases plasma endothelin and atrial natriuretic peptide levels and preload in patients with left ventricular dysfunction after cardiac surgery. Tohmo H, Karanko M, Klossner J, Scheinin M, Viinamäki O, Neuvonen P, Ruskoaho H. J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):585-90. PubMed ID: 9263090 [Abstract] [Full Text] [Related]
28. ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada. Parker AB, Azevedo ER, Baird MG, Smith SJ, Arnold JM, Humen DP, Moe GW, Parker JO, Butt RW, Parker JD. Am Heart J; 1999 Nov; 138(5 Pt 1):843-8. PubMed ID: 10539814 [Abstract] [Full Text] [Related]
29. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure. Dickstein K, Aarsland T, Woie L, Abrahamsen AM, Fyhrquist F, Cummings S, Gomex HJ, Hagen E, Kristianson K. Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850 [Abstract] [Full Text] [Related]
30. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Sütsch G, Kiowski W, Yan XW, Hunziker P, Christen S, Strobel W, Kim JH, Rickenbacher P, Bertel O. Circulation; 1998 Nov 24; 98(21):2262-8. PubMed ID: 9826312 [Abstract] [Full Text] [Related]
31. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. Insel J, Mirvis DM, Boland MJ, Cinquegrani MP, Shanes J, Rubin SA, Whalen JJ. Clin Pharmacol Ther; 1989 Mar 24; 45(3):312-20. PubMed ID: 2537699 [Abstract] [Full Text] [Related]
35. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE. Arterioscler Thromb Vasc Biol; 2004 Jun 24; 24(6):1043-8. PubMed ID: 15105283 [Abstract] [Full Text] [Related]
38. Bolus versus continuous low dose of enalaprilat in congestive heart failure with acute refractory decompensation. Podbregar M, Voga G, Horvat M, Zuran I, Krivec B, Skale R, Pareznik R. Cardiology; 1999 Jun 24; 91(1):41-9. PubMed ID: 10393397 [Abstract] [Full Text] [Related]
39. Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill. Boldt J, Papsdorf M, Kumle B, Piper S, Hempelmann G. Crit Care Med; 1998 Oct 24; 26(10):1663-70. PubMed ID: 9781723 [Abstract] [Full Text] [Related]
40. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure]. Mitrovic V, Mudra H, Bonzel T, Schmidt W, Schlepper M. Z Kardiol; 1996 Nov 24; 85(11):828-38. PubMed ID: 9064945 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]